Alphatec shares last traded at $10.1270, with a volume of 334,817 shares changing hands. Wall Street Zen downgraded Alphatec from a “buy” rating to a “hold” rating in a research note on Sunday, July 12th. One analyst has rated the stock with a Strong Buy rating, twelve have assigned a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the stock. In related news, Director Karen K. Mcginnis sold 6,050 shares of Alphatec stock in a transaction that occurred on Thursday, June 11th. Morgan Stanley now owns 4,340,936 shares of the medical technology company’s stock worth $91,333,000 after purchasing an additional 784,191 shares in the last quarter.